Approach to Fungal Infections in Human Immunodeficiency Virus-Infected Individuals: Pneumocystis and Beyond

Clin Chest Med. 2017 Sep;38(3):465-477. doi: 10.1016/j.ccm.2017.04.008. Epub 2017 Jun 3.

Abstract

Many fungi cause pulmonary disease in patients with human immunodeficiency virus (HIV) infection. Pathogens include Pneumocystis jirovecii, Cryptococcus neoformans, Aspergillus spp, Histoplasma capsulatum, Coccidioides spp, Blastomyces dermatitidis, Paracoccidioides brasiliensis, Talaromyces marneffei, and Emmonsia spp. Because symptoms are frequently nonspecific, a high index of suspicion for fungal infection is required for diagnosis. Clinical manifestations of fungal infection in HIV-infected patients frequently depend on the degree of immunosuppression and the CD4+ helper T cell count. Establishing definitive diagnosis is important because treatments differ. Primary and secondary prophylaxes depend on CD4+ helper T cell counts, geographic location, and local prevalence of disease.

Keywords: Human immunodeficiency virus; Mycoses; Opportunistic infection; Pneumocystis; Pneumonia.

Publication types

  • Review

MeSH terms

  • HIV Infections / complications*
  • Humans
  • Mycoses / therapy*
  • Pneumocystis / pathogenicity*
  • Pneumonia, Pneumocystis / therapy*